The Pep Club Full-Stack Telehealth Platform Launches Tuesday June 30, 2026 (Co-Founded by Greg Yuna and Gabriella Shak): Prescription Therapy and Physician-Guided Peptide Protocols Paired with At-Home Capillary Biomarker Testing Across Weight Management, Hormone Optimization, Sexual Health, Hair Restoration, Skin, IV/Vitamin Support, Peptides, and Longevity
The Pep Club, a direct-to-consumer telehealth platform co-founded by entrepreneur Greg Yuna (CEO) and Gabriella Shak, publicly launched Tuesday June 30, 2026 at thepepclub.com with a full-stack model pairing prescription medication therapy and physician-guided peptide protocols with at-home biomarker testing. The platform spans more than a dozen categories including weight management (GLP-1 prescriptions), hormone optimization (testosterone, thyroid), sexual health (PT-141, sildenafil, tadalafil), hair restoration (finasteride, GHK-Cu, oral minoxidil), skin and acne (tretinoin, hyaluronic acid, cosmetic peptides), IV and vitamin support, peptides (BPC-157, TB-500, ipamorelin, sermorelin among the compounded offerings), and longevity. All protocols are reviewed and supervised by licensed clinicians and fulfilled through licensed pharmacy partners. The differentiator is the at-home capillary biomarker collection device that lets patients submit lab-quality panels for personalization and monitoring. Yuna, co-founder and CEO: 'When you combine real at-home testing with both prescription and peptide therapy under licensed clinical supervision, you can actually personalize treatment to the individual.' The platform launches into a competitive telehealth market that already includes Hims & Hers, LifeMD, Henry Meds, and Ro; the Pep Club differentiator is the peptide-plus-biomarker integration.